Optimizing a Candida Biofilm Microtiter Plate Model for Measurement of Antifungal Susceptibility by Tetrazolium Salt Assay

Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene

(2010) J. E. Nett et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genetic Basis ofCandidaBiofilm Resistance Due to Drug‐Sequestering Matrix Glucan

(2010) Jeniel E. Nett et al.   JOURNAL OF INFECTIOUS DISEASES

In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans Isolates

(2009) M. J. Jacobson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms

(2008) C. J. Seneviratne et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Biocide Susceptibility in Candida albicans Biofilms

(2008) J. E. Nett et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms

(2008) P. Uppuluri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms

(2008) E. Mowat et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro growth and analysis of Candida biofilms

(2008) Jyotsna Chandra et al.   Nature Protocols